Outcome in Heart Failure Treated With Levothyroxine Outcome in Heart Failure Treated With Levothyroxine
A new study examines the long-term effects of levothyroxine treatment in patients with heart failure. What have we learned?Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 2, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Lannett Enters Into Distribution Agreement For Levothyroxine
PHILADELPHIA, July 8, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into a future exclusive supply and distribution agreement for the approved Levothyroxine Sodium Tablets USP of Ce... Biopharmaceuticals, Generics, Distribution Lannett Company, Levothyroxine, Cediprof, Neolpharma Pharmaceutical Group (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 8, 2019 Category: Pharmaceuticals Source Type: news

Generic vs Brand-Name Levothyroxine: Same Cardiac Event Risk? Generic vs Brand-Name Levothyroxine: Same Cardiac Event Risk?
' There ' s been a lot of discussion of generic versus brand L-T4, and this is just one other piece of information in a very large group of patients, but it needs follow-up studies, ' says lead author.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 2, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Similar CV Event Rates Seen for Generic, Brand Levothyroxine
THURSDAY, June 27, 2019 -- Cardiovascular event rates are similar for patients with newly treated hypothyroidism receiving generic and brand levothyroxine (L-T4), according to a study published online April 26 in the Mayo Clinic Proceedings. Robert... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 27, 2019 Category: Pharmaceuticals Source Type: news

Over-prescribed levothyroxine: Mayo Clinic Radio Health Minute
The most commonly prescribed drug in the U.S. also may be one of the most overprescribed for older individuals. Levothyroxine is a medication used to treat low thyroid hormone levels. However, a study published this spring in the New England Journal of Medicine reported that patients with subclinical thyroid hormone levels received no benefit from the drug. Mayo [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 20, 2019 Category: Databases & Libraries Source Type: news

Study finds similar cardiovascular outcomes for generic, brand-name drugs for hypothyroidism
JACKSONVILLE, Fla. -- A new study by Mayo Clinic researchers may have broad implications for treatment of patients with predominantly benign thyroid disease and newly treated hypothyroidism. The study, to be published in Mayo Clinic Proceedings in July, looked at whether generic and brand-name levothyroxine therapy affected hospitalization for cardiovascular events for those patients who [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 18, 2019 Category: Databases & Libraries Source Type: news

Westminster Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Levothyroxine and Liothyronine (Thyroid Tablets, USP) Due to Risk of Adulteration
Westminster Pharmaceuticals, LLC is voluntarily recalling all lots, within expiry, of Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15 mg, 30 mg, 60 mg, 90 mg,& 120 mg to the wholesale level. These products are being recalled as a precaution because they were manufactured using active pharmaceutical ingredients that were sourced prior to the FDA ’s Import Alert of Sichuan Friendly Pharmaceutical Co., Ltd., which as a result of a 2017 inspection were found to have deficiencies with Current Good Manufacturing Practices (cGMP). Substandard cGMP practices could represent the possibility of risk being introduced into ...
Source: FDA Center for Drug Evaluation and Research - What's New - May 24, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Why doctors now warn against routinely treating mild thyroid issues
Giving daily levothyroxine pills to people with a mild abnormality called subclinical hypothyroidism offers no benefit, a review of 21 clinical trials suggests. (Source: CBC | Health)
Source: CBC | Health - May 17, 2019 Category: Consumer Health News Tags: News/Health Source Type: news

Mild Hypothyroidism Being Overtreated, Avoid Pills, Says Panel Mild Hypothyroidism Being Overtreated, Avoid Pills, Says Panel
In a"strong recommendation," an international panel of experts advise that patients with subclinical hypothyroidism should not be routinely prescribed levothyroxine; evidence shows few benefits.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 16, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Hundreds of thousands of people in the UK may be unnecessarily taking drugs
Figures from NHS Digital show that more than 32million prescriptions were issued in England in 2018 for levothyroxine. This is up from 20,426,378 in 2008. (Source: the Mail online | Health)
Source: the Mail online | Health - May 15, 2019 Category: Consumer Health News Source Type: news

TSH and Pregnancy: Finding Your Way Out of the Gray Zone TSH and Pregnancy: Finding Your Way Out of the Gray Zone
Which patients with subclinical hypothyroidism in pregnancy would benefit from levothyroxine treatment? Dr Korevaar shares three tips to help guide the decision-making process.Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 9, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Commentary Source Type: news

ENDO: Levothyroxine Does Not Up Fertility in Women With TPO Ab
TUESDAY, March 26, 2019 -- For euthyroid women with thyroid peroxidase antibodies and a history of miscarriage or infertility, levothyroxine does not result in an increased rate of live births versus placebo, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 26, 2019 Category: Pharmaceuticals Source Type: news

Levothyroxine provides no pregnancy benefits to women with thyroid antibodies
According to data, presented at the Endocrine Society's annual meeting, euthyroid women treated with levothyroxine did not have improved chances of having a live birth, if they were also positive for thyroid antibodies.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - March 26, 2019 Category: Endocrinology Source Type: news

Levothyroxine Tx Doesn't Deliver in Women With TPO Antibodies
(MedPage Today) -- Preterm births and neonatal outcomes not significantly different than placebo (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - March 23, 2019 Category: OBGYN Source Type: news

Levothyroxine treatment in women with thyroid antibodies may not increase live birth rate
(The Endocrine Society) Treating women who have thyroid antibodies, but normal thyroid function, with a medicine called Levothyroxine does not make them more likely to deliver a live baby, new research from the United Kingdom suggests. The research will be presented Saturday, March 23 at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La., and published in the New England Journal of Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 23, 2019 Category: International Medicine & Public Health Source Type: news